Isoniazid preventive therapy modulates Mycobacterium tuberculosis-specific T-cell responses in individuals with latent tuberculosis and type 2 diabetes
Abstract Diabetes mellitus (DM) is a significant contributor to tuberculosis (TB) incidence and poor treatment outcomes. This study explored the impact of isoniazid preventive therapy (IPT) on Mycobacterium tuberculosis (Mtb)-specific T-cell memory phenotypes and function among participants with lat...
Saved in:
| Main Authors: | Phillip Ssekamatte, Diana Sitenda, Rose Nabatanzi, Marjorie Nakibuule, Davis Kibirige, Andrew Peter Kyazze, David Patrick Kateete, Bernard Ssentalo Bagaya, Obondo James Sande, Reinout van Crevel, Stephen Cose, Irene Andia Biraro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-95386-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic dysfunction impairs Mycobacterium tuberculosis-specific cytokine and chemokine responses in latent tuberculosis and type 2 diabetes mellitus
by: Phillip Ssekamatte, et al.
Published: (2025-08-01) -
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
by: Valentina Gerussi, et al.
Published: (2025-03-01) -
Relapse of Pulmonary Tuberculosis in Patients with Resistance to Isoniazid
by: I. A. Burmistrova, et al.
Published: (2023-07-01) -
Differentiated Approaches to Chemotherapy of Respiratory Tuberculosis in Children Exposed to Isoniazid Resistant Tuberculosis
by: M. F. Gubkina, et al.
Published: (2021-09-01) -
The efficacy of the combination drug of hydroxymethylquinoxalinedioxide + isoniazid lyophilisate in the treatment of bronchial tuberculosis
by: A. A. Stаrshinovа
Published: (2019-05-01)